Literature DB >> 20878277

Recent advances in the medical and surgical treatment of priapism.

Adam Shrewsberry1, Aaron Weiss, Chad W M Ritenour.   

Abstract

Priapism often is a urological emergency that requires prompt and aggressive therapy. Over the past several years, research has provided better understanding and new insights into the pathophysiology of this disorder. Subsequently, new treatments have been tried and developed. This report focuses on the latest review of therapy for ischemic and nonischemic priapism.

Entities:  

Mesh：

Year:  2010        PMID： 20878277     DOI： 10.1007/s11934-010-0142-4

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  49 in total

1.  VENOUS BYPASS TO CONTROL PRIAPISM.

Authors:  J T GRAYHACK; W MCCULLOUGH; V J O'CONOR; O TRIPPEL
Journal:  Invest Urol       Date:  1964-03

2.  Intracorporeal phenylephrine in the treatment of priapism.

Authors:  N Muruve; D H Hosking
Journal:  J Urol       Date:  1996-01       Impact factor: 7.450

3.  Changing surgical concepts in the treatment of priapism.

Authors:  C J Ercole; J E Pontes; J M Pierce
Journal:  J Urol       Date:  1981-02       Impact factor: 7.450

4.  Successful management of stuttering priapism using home self-injections of the alpha-agonist metaraminol.

Authors:  Michael McDonald; Richard A Santucci
Journal:  Int Braz J Urol       Date:  2004 Mar-Apr       Impact factor: 1.541

5.  T-shaped shunt and intracavernous tunneling for prolonged ischemic priapism.

Authors:  William O Brant; Maurice M Garcia; Anthony J Bella; Tom Chi; Tom F Lue
Journal:  J Urol       Date:  2009-02-23       Impact factor: 7.450

Review 6.  Up and down-regulation of phosphodiesterase-5 as related to tachyphylaxis and priapism.

Authors:  Guiting Lin; Zhong-Cheng Xin; Tom F Lue; Ching-Shwun Lin
Journal:  J Urol       Date:  2003-08       Impact factor: 7.450

Review 7.  Molecular pharmacotherapeutic targeting of PDE5 for preservation of penile health.

Authors:  Arthur L Burnett
Journal:  J Androl       Date:  2007-10-17

8.  Follow-up of sickle cell disease patients with priapism treated by hydroxyurea.

Authors:  Sara T O Saad; Camila Lajolo; Simone Gilli; José Francisco C Marques Júnior; Carmen S Lima; Fernando F Costa; Valder R Arruda
Journal:  Am J Hematol       Date:  2004-09       Impact factor: 10.047

9.  Investigating the effects of high-dose phenylephrine in the management of prolonged ischaemic priapism.

Authors:  Asif Muneer; Suks Minhas; Alex Freeman; Pardeep Kumar; David J Ralph
Journal:  J Sex Med       Date:  2008-05-07       Impact factor: 3.802

10.  Inhibition of sexual reflexes by lumbosacral injection of a GABAB agonist in the male rat.

Authors:  D Bitran; S A Miller; D B McQuade; R E Leipheimer; B D Sachs
Journal:  Pharmacol Biochem Behav       Date:  1988-11       Impact factor: 3.533
View more
  1 in total

1.  Outcome and erectile function following treatment of priapism: An institutional experience.

Authors:  Dilip Kumar Pal; Deepak Kumar Biswal; Bastab Ghosh
Journal:  Urol Ann       Date:  2016 Jan-Mar
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.